Mohan R. Patil

Perth, WA 6000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease.

Acute Effects of Cannabinoid Combination Therapies in a Western Diet-Induced Murine Model of Metabolic Liver Disease.

Journal: International journal of molecular sciences

Published: March 23, 2026

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

Journal: Bioscience reports

Published: January 29, 2026

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies.

Journal: Bioscience reports

Published: October 23, 2025

Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis.

Cannabidiol Enhances the Therapeutic Efficacy of Olsalazine and Cyclosporine in a Murine Model of Colitis.

Journal: International journal of molecular sciences

Published: July 07, 2025

Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions.

Targeting the LPI/GPR55 Axis in MAFLD and MASH: Novel Insights, Therapeutic Strategies and Future Directions.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 02, 2025

Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without Diabetes.

Therapeutic Potential of Sotagliflozin in Animal Models of Non-alcoholic Fatty Liver Disease with and without Diabetes.

Journal: Drug research

Published: April 14, 2025

Empirical modelling of suspended sediments using spectral data from spectroradiometer and sentinel-2 in Mula Dam Reservoir, Maharashtra, India.

Empirical modelling of suspended sediments using spectral data from spectroradiometer and sentinel-2 in Mula Dam Reservoir, Maharashtra, India.

Journal: Scientific reports

Published: January 30, 2025

Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.

Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 09, 2025

Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic Innovations.

Comprehensive Assessment of Cannabidiol and HU308 in Acute and Chronic Colitis Models: Efficacy, Safety, and Mechanistic Innovations.

Journal: Cells

Published: October 24, 2024

Chronic metabolic effects of novel gut-oriented small-molecule GPR119 agonists in diet-induced obese mice.

Chronic metabolic effects of novel gut-oriented small-molecule GPR119 agonists in diet-induced obese mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 04, 2024

Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity.

Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesity.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 23, 2024

G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?

G protein-coupled receptors driven intestinal glucagon-like peptide-1 reprogramming for obesity: Hope or hype?

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 18, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026